Amdocs (NASDAQ:DOX) Hits New 52-Week Low Following Weak Earnings

Amdocs Limited (NASDAQ:DOX)’s share price hit a new 52-week low during trading on Tuesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $74.25 and last traded at $73.3010, with a volume of 2350850 shares changing hands. The stock had previously closed at $81.01.

The technology company reported $1.81 EPS for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.46% and a return on equity of 19.78%. The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. During the same period last year, the firm earned $1.66 EPS. Amdocs’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS.

Amdocs Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st were issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Wednesday, December 31st. Amdocs’s payout ratio is presently 41.78%.

More Amdocs News

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: T‑Mobile extended a strategic multi‑year agreement with Amdocs covering managed services, software development and AI initiatives — a material customer renewal that supports recurring revenue. T‑Mobile strategic agreement
• Positive Sentiment: VIDAA selected Amdocs MarketONE to power OTT subscription and bundled streaming on smart TVs — a product win that could expand MarketONE adoption and monetization opportunities. VIDAA selects MarketONE
• Positive Sentiment: Amdocs launched aOS, an “agentic operating system” aimed at embedding generative AI into telecom operations — a strategic product initiative that could drive long‑term differentiation. Amdocs introduces aOS
• Positive Sentiment: Shareholders approved board proposals at the AGM, including a boosted dividend and expansion of the employee share plan — supportive for income investors and employee alignment. AGM results
• Neutral Sentiment: The company posted press materials, a slide deck and a conference call recording for the quarter — useful for parsing results and management commentary but not a market mover by itself. Press release / slide deck
• Neutral Sentiment: Short‑interest reports in recent feeds show inconsistent/zero values (NaN/0) and days‑to‑cover of 0.0 — the published data appears unreliable and shouldn’t be interpreted as fresh bearish positioning.
• Negative Sentiment: MarketBeat and some market sources reported Amdocs’ quarter at $1.63 EPS, missing consensus (~$1.75) — that reported miss likely triggered immediate selling. MarketBeat earnings report
• Negative Sentiment: Conflicting headlines — Zacks published a report showing an adjusted beat ($1.81) while other outlets showed a $1.63 EPS result — created investor confusion over the company’s actual performance and adjustments, amplifying volatility and downside pressure. Zacks earnings note

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on DOX shares. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Stifel Nicolaus reduced their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Finally, Bank of America decreased their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $97.00.

Hedge Funds Weigh In On Amdocs

Several institutional investors have recently modified their holdings of the company. Pzena Investment Management LLC lifted its position in Amdocs by 0.6% in the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock worth $540,976,000 after buying an additional 42,184 shares during the last quarter. LSV Asset Management raised its stake in shares of Amdocs by 7.6% during the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock worth $299,376,000 after acquiring an additional 257,193 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in shares of Amdocs by 1.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after acquiring an additional 54,676 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Amdocs by 3.0% in the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after purchasing an additional 91,900 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Amdocs by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock valued at $251,602,000 after purchasing an additional 9,207 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

Amdocs Stock Performance

The company has a market cap of $7.99 billion, a P/E ratio of 14.66, a price-to-earnings-growth ratio of 1.37 and a beta of 0.40. The company’s fifty day moving average is $80.37 and its 200 day moving average is $82.64. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.23.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.